SARS-CoV-2 & Influenza A/B Antigen Combined Detection Kit (Colloidal Gold)

This kit is used for in vitro qualitative detection of SARS-CoV-2, influenza A, and influenza B antigens, as an auxiliary diagnosis of SARS-CoV-2, influenza A virus, and influenza B virus infection. The test results are for clinical reference only and cannot be used as the sole basis for diagnosis.

SKU Code
AENE-RT098
Approval
On request
Product Type
Assay / Kit
Status
Available

This kit is used for in vitro qualitative detection of SARS-CoV-2, influenza A, and influenza B antigens, as an auxiliary diagnosis of SARS-CoV-2, influenza A virus, and influenza B virus infection. The test results are for clinical reference only and cannot be used as the sole basis for diagnosis.

Product typeAssay / Kit
Technology platformColloidal Gold
Application areaCOVID-19

Certificate

CE

Epidemiology

Coronavirus Disease 2019 (COVID-19) is a pneumonia caused by infection with the novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a betacoronavirus, with enveloped, round or oval particles measuring 60–140 nm in diameter. Humans are generally susceptible to SARS-CoV-2, and the main sources of infection are confirmed COVID-19 patients and asymptomatic carriers of SARS-CoV-2.

Influenza viruses belong to the Orthomyxoviridae family and are segmented, negative-strand RNA viruses. Based on antigenic differences in nucleocapsid protein (NP) and matrix protein (M), they are divided into types A, B, and C; recently discovered influenza viruses are classified as type D. Influenza A and B are the primary pathogens of human influenza, characterized by wide prevalence and high infectivity, and they can cause severe infections in children, the elderly, and immunocompromised individuals.

SKU codeAENE-RT098
Storage temperature4 - 30℃ at sealed and dry condition
Sample typeNasopharyngeal swab、Oropharyngeal swab、Nasal swab
Shelf life24 months
Auxiliary instrumentsNot required
Extra ConsumablesNot required
Detection time15-20 mins
SpecificityThere is no cross-reaction with pathogens such as Human coronavirus HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63, respiratory syncytial virus type A,B, parainfluenza virus type 1, 2, 3, rhinovirus A, B, C, adenovirus 1, 2, 3, 4, 5, 7,55,Chlamydia pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae,Neisseria meningitidis, Staphylococcus aureus, Streptococcus pneumoniae and other pathogens.
ApprovalOn request
DocumentsDatasheet, IFU, SDS, COA / conformance, origin, and export documents where available

FAQ

What should be confirmed before quotation?

Sample context, collection method, and extraction workflow should be confirmed before final kit selection.

Which documents can be requested?

Datasheet, IFU, SDS, COA / conformance, origin, insurance, and export documents can be checked where available.

Can the format be adjusted for different workflows?

Liquid or lyophilized format options should be confirmed together with instrument compatibility and shipment requirements.

Send the essentials for a useful first reply.

Share the application, sample type, format, destination, and expected quantity so AeneBio can route AENE-RT098 to the right quote or sample discussion.